Mergers, acquisitions, and exit events mark key milestones in a company's cycle. Morgan Lewis provides articles and presentations to help effectively understand some of the most important decisions facing a company. Materials of particular interest to technology and life sciences companies are identified.
| Acquiring Intellectual Property: Potential Pitfalls (Chapter 32), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis) This chapter identifies and discusses common pitfalls associated with certain provisions of merger and acquisition agreements. In particular, it focuses on certain definitions and on representations and warranties. These provisions are typically highly negotiated, and in some instances cause the parties to terminate negotiations prior to signing, or form the basis of disputes after closing.  View the chapter. |
 LifeSci |
| Biotechnology Mergers and Acquisitions This presentation by Morgan Lewis partner Emilio Ragosa highlights several important aspects when entering a merger or acquisition. View the presentation. |
LifeSci |
| Institutional Due Diligence This presentation by Morgan Lewis partner Peter Watt-Morse showcases ongoing institutional due diligence efforts needed by start-ups. View the presentation. |
LifeSciTech |
| Issues That Must be Addressed in a Life Sciences M&A (Chapter 30), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis) This chapter outlines a number of issues that a life sciences company faces in a merger or acquisition. View the chapter. |
LifeSci |
| Key Contract Provisions for Asset Purchase Agreements (Chapter 31), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis) This chapter outlines key contract provisions that should be considered when negotiating and drafting asset purchase agreements. View the chapter. |
LifeSci |
| Outline of Issues for a Biotech Company to Consider in Preparing for an IPO (Chapter 28), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis) This chapter provides an overview of many of the issues that will need to be addressed by a company considering an IPO. View the chapter. |
LifeSciTech |
| Outline of Issues to Consider in Preparing for an IPO View the outline. |
LifeSciTech |
| Overcoming the Unique Challenges in Private vs. Public Life Sciences M&A (Chapter 29), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis) This chapter outlines some of the key points in understanding the differences between private companies’ and public companies’ reasons for entering into a merger or acquisition, the different structures for private and public merger and acquisition deals, and the limitations that are placed on structures for public companies. View the chapter. |
LifeSci |
| Preparing for a Biotechnology M&A—Corporate and Regulatory Insight to Keep Ahead of the Competition This presentation by Morgan Lewis partners Stephen Mahinka and Richard Aldridge showcased corporate and regulatory aspects that life sciences companies need to focus on when preparing for a mergers and acquisitions deal. View the presentation. |
LifeSciTech |
| Preparing for an IPO This presentation by Morgan Lewis partner Steve Cohen outlines steps required for an IPO. View the outline. |
LifeSciTech |
| Preparing for a Liquidity Event This outline by Morgan Lewis highlights business issues to consider in preparing for a liquidity event, analyzing which type of liquidity event is right for you, and considering potential terms you will need to consider and negotiate. View the outline. |
LifeSciTech |